Log In
Print this Print this

infigratinib (BGJ398)

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionFibroblast growth factor (FGF) receptor (FGFR) kinase inhibitor
Molecular Target Fibroblast growth factor (FGF) receptor (FGFR)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today